Effects of hypoxia, glucose deprivation and acidosis on phosphatidylcholine synthesis in HL-1 cardiomyocytes. CTP:phosphocholine cytidylyltransferase activity correlates with sarcolemmal disruption
- 27 January 2006
- journal article
- Published by Portland Press Ltd. in Biochemical Journal
- Vol. 394 (1) , 325-334
- https://doi.org/10.1042/bj20050834
Abstract
A decrease in [3H]Cho (choline) incorporation in to PtdCho (phos-phatidylcholine) preceded the onset of LDH (lactate dehydrogenase) release in HL-1 cardiomyocytes submitted to simulated ischaemia. This observation led us to examine the role of PtdCho synthesis in sarcolemmal disruption in HL-1 cardiomyocytes. To address this objective we analysed the individual effects of hypoxia, glucose deprivation and acidosis, three prominent components of ischaemia, on the different steps of the Kennedy pathway for the synthesis of PtdCho. Pulse and pulse-chase experiments with [3H]Cho, performed in whole HL-1 cells submitted to hypoxia or normoxia, in the presence or absence of glucose at different pHs indicated first, that CK (choline kinase) was inhibited by hypoxia and acidosis, whereas glucose deprivation exacerbated the inhibition caused by hypoxia. Second, the rate-limiting reaction in PtdCho synthesis, catalysed by CCT (CTP:phosphocholine cytidylyltransferase), was inhibited by hypoxia and glucose deprivation, but unexpectedly activated by acidosis. In cellfree system assays, acidosis inhibited both CK and CCT. In experiments performed in whole cells, the effect of acidosis was likely to be direct on CK, but indirect or intact-cell-dependent on CCT. Since hypoxia and glucose deprivation favoured membrane disruption, but acidosis prevented it, we hypothesized that the modulation of CCT could be an important determinant of cell survival. Supporting this hypothesis, we show that CCT activity in whole-cell experiments clearly correlated with LDH release, but not with ATP concentration. Altogether our results suggest a significant role for CCT activity in sarcolemmal disruption during ischaemia.Keywords
This publication has 47 references indexed in Scilit:
- Release of choline in the isolated heart, an indicator of ischemic phospholipid degradation and its protection by ischemic preconditioning: No evidence for a role of phospholipase DLife Sciences, 2004
- Urocortin protects cardiac myocytes from ischemia/reperfusion injury by attenuating calcium insensitive phospholipase A2gene expressionThe FASEB Journal, 2003
- Oxidized Lipoproteins Inhibit Surfactant Phosphatidylcholine Synthesis via Calpain-mediated Cleavage of CTP:Phosphocholine CytidylyltransferaseJournal of Biological Chemistry, 2003
- Inhibition of phosphatidylcholine synthesis precedes apoptosis induced by C2-ceramideNeuroReport, 2000
- Tumor Necrosis Factor-α Inhibits Expression of CTP:Phosphocholine CytidylyltransferaseJournal of Biological Chemistry, 2000
- CTP:Phosphocholine Cytidylyltransferase: Insights into Regulatory Mechanisms and Novel FunctionsBiochemical and Biophysical Research Communications, 1999
- A Genetic Defect in Phosphatidylcholine Biosynthesis Triggers Apoptosis in Chinese Hamster Ovary CellsPublished by Elsevier ,1996
- Organization and function of sarcolemmal phospholipids in control and ischemic/reperfused cardiomyocytesJournal of Molecular and Cellular Cardiology, 1995
- Phosphatidylcholine metabolism in ischemic and hypoxic heartsMolecular and Cellular Biochemistry, 1992
- Phosphatidylcholine biosynthesis in myocardial ischaemiaJournal of Molecular and Cellular Cardiology, 1989